139 related articles for article (PubMed ID: 1707692)
21. Cytokine augmentation of HIV-1 LTR-driven gene expression in neural cells.
Swingler S; Easton A; Morris A
AIDS Res Hum Retroviruses; 1992 Apr; 8(4):487-93. PubMed ID: 1599755
[TBL] [Abstract][Full Text] [Related]
22. Pentoxifylline suppresses transduction by HIV-1-based vectors.
Smith JA; Nunnari G; Preuss M; Pomerantz RJ; Daniel R
Intervirology; 2007; 50(5):377-86. PubMed ID: 17938572
[TBL] [Abstract][Full Text] [Related]
23. Dioxin activates human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells by enhancing NF-kappa B activity and production of tumor necrosis factor-alpha.
Gollapudi S; Kim CH; Patel A; Sindhu R; Gupta S
Biochem Biophys Res Commun; 1996 Sep; 226(3):889-94. PubMed ID: 8831706
[TBL] [Abstract][Full Text] [Related]
24. Regulation of human immunodeficiency virus type 1 replication in human T lymphocytes by nitric oxide.
Jiménez JL; González-Nicolás J; Alvarez S; Fresno M; Muñoz-Fernández MA
J Virol; 2001 May; 75(10):4655-63. PubMed ID: 11312336
[TBL] [Abstract][Full Text] [Related]
25. Substance P enhances HIV-1 replication in latently infected human immune cells.
Li Y; Douglas SD; Song L; Sun S; Ho WZ
J Neuroimmunol; 2001 Dec; 121(1-2):67-75. PubMed ID: 11730941
[TBL] [Abstract][Full Text] [Related]
26. Effect of recombinant human growth hormone on acute and chronic human immunodeficiency virus infection in vitro.
Laurence J; Grimison B; Gonenne A
Blood; 1992 Jan; 79(2):467-72. PubMed ID: 1730091
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: involvement of NF-kappaB and NFAT.
Navarro J; Punzón C; Jiménez JL; Fernández-Cruz E; Pizarro A; Fresno M; Muñoz-Fernández MA
J Virol; 1998 Jun; 72(6):4712-20. PubMed ID: 9573235
[TBL] [Abstract][Full Text] [Related]
28. Progesterone inhibits HIV-1 replication in human trophoblast cells through inhibition of autocrine tumor necrosis factor secretion.
Muñoz LD; Serramía MJ; Fresno M; Muñoz-Fernández MA
J Infect Dis; 2007 May; 195(9):1294-302. PubMed ID: 17396998
[TBL] [Abstract][Full Text] [Related]
29. Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.
Chen H; He J; Fong S; Wilcox G; Wood C
J Virol; 2000 Mar; 74(6):2703-13. PubMed ID: 10684286
[TBL] [Abstract][Full Text] [Related]
30. Opiates, human peripheral blood mononuclear cells, and HIV.
Peterson PK; Sharp BM; Gekker G; Jackson B; Balfour HH
Adv Exp Med Biol; 1991; 288():171-8. PubMed ID: 1950731
[No Abstract] [Full Text] [Related]
31. Interaction of pregnancy steroid hormones and zidovudine in inhibition of HIV type 1 replication in monocytoid and placental Hofbauer cells: implications for the prevention of maternal-fetal transmission of HIV.
Lee AW; Mitra D; Laurence J
AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1235-42. PubMed ID: 9310291
[TBL] [Abstract][Full Text] [Related]
32. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
Popik W; Pitha PM
Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human immunodeficiency virus type 1 replication in latently infected cells by a novel IkappaB kinase inhibitor.
Victoriano AF; Asamitsu K; Hibi Y; Imai K; Barzaga NG; Okamoto T
Antimicrob Agents Chemother; 2006 Feb; 50(2):547-55. PubMed ID: 16436709
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
Kinter AL; Biswas P; Alfano M; Justement JS; Mantelli B; Rizzi C; Gatti AR; Vicenzi E; Bressler P; Poli G
Mol Med; 2001 Oct; 7(10):668-78. PubMed ID: 11713366
[TBL] [Abstract][Full Text] [Related]
36. Soluble tumor necrosis factor receptor: inhibition of human immunodeficiency virus activation.
Howard OM; Clouse KA; Smith C; Goodwin RG; Farrar WL
Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2335-9. PubMed ID: 7681592
[TBL] [Abstract][Full Text] [Related]
37. Canventol inhibits HIV-1 replication by Tat-induced Tar-independent mechanism.
Biswas DK; Tius MA; Zhuo J; Pardee AB
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):120-7. PubMed ID: 8680882
[TBL] [Abstract][Full Text] [Related]
38. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
[TBL] [Abstract][Full Text] [Related]
39. Sodium valproate, an anticonvulsant drug, stimulates human immunodeficiency virus type 1 replication independently of glutathione levels.
Moog C; Kuntz-Simon G; Caussin-Schwemling C; Obert G
J Gen Virol; 1996 Sep; 77 ( Pt 9)():1993-9. PubMed ID: 8810995
[TBL] [Abstract][Full Text] [Related]
40. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
